全文获取类型
收费全文 | 1813篇 |
免费 | 118篇 |
出版年
2023年 | 8篇 |
2022年 | 10篇 |
2021年 | 36篇 |
2020年 | 15篇 |
2019年 | 42篇 |
2018年 | 44篇 |
2017年 | 27篇 |
2016年 | 42篇 |
2015年 | 81篇 |
2014年 | 110篇 |
2013年 | 129篇 |
2012年 | 135篇 |
2011年 | 150篇 |
2010年 | 91篇 |
2009年 | 87篇 |
2008年 | 119篇 |
2007年 | 113篇 |
2006年 | 107篇 |
2005年 | 109篇 |
2004年 | 107篇 |
2003年 | 80篇 |
2002年 | 68篇 |
2001年 | 14篇 |
2000年 | 11篇 |
1999年 | 18篇 |
1998年 | 17篇 |
1997年 | 12篇 |
1996年 | 10篇 |
1995年 | 16篇 |
1994年 | 14篇 |
1993年 | 9篇 |
1992年 | 11篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 5篇 |
1988年 | 6篇 |
1987年 | 3篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 11篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1976年 | 2篇 |
1975年 | 4篇 |
1972年 | 2篇 |
1970年 | 2篇 |
排序方式: 共有1931条查询结果,搜索用时 15 毫秒
911.
912.
Roberto Erro Carmine Vitale Marianna Amboni Marina Picillo Marcello Moccia Katia Longo Gabriella Santangelo Anna De Rosa Roberto Allocca Flavio Giordano Giuseppe Orefice Giuseppe De Michele Lucio Santoro Maria Teresa Pellecchia Paolo Barone 《PloS one》2013,8(8)
Background
The variability in the clinical phenotype of Parkinson’s disease seems to suggest the existence of several subtypes of the disease. To test this hypothesis we performed a cluster analysis using data assessing both motor and non-motor symptoms in a large cohort of newly diagnosed untreated PD patients.Methods
We collected data on demographic, motor, and the whole complex of non-motor symptoms from 100 consecutive newly diagnosed untreated outpatients. Statistical cluster analysis allowed the identification of different subgroups, which have been subsequently explored.Results
The data driven approach identified four distinct groups of patients, we have labeled: 1) Benign Pure Motor; 2) Benign mixed Motor-Non-Motor; 3) Non-Motor Dominant; and 4) Motor Dominant.Conclusion
Our results confirmed the existence of different subgroups of early PD patients. Cluster analysis revealed the presence of distinct subtypes of patients profiled according to the relevance of both motor and non-motor symptoms. Identification of such subtypes may have important implications for generating pathogenetic hypotheses and therapeutic strategies. 相似文献913.
Orsolya Timár Zoltán Szekanecz Gy?rgy Kerekes Judit Végh Anna V Oláh Gábor Nagy Zoltán Csiki Katalin Dankó Szilvia Szamosi ágnes Németh Pál Soltész Gabriella Szücs 《Arthritis research & therapy》2013,15(5):R105
Introduction
We studied the effect of rosuvastatin on endothelial and macrovascular function, cardiovascular risk factors and the complement pathway in patients with systemic sclerosis (SSc).Methods
Altogether 28 patients with SSc underwent laboratory and complex vascular assessments before and after six months of 20 mg rosuvastatin treatment. Flow-mediated dilation (FMD) of the brachial artery, as well as carotid artery intima-media thickness (ccIMT), carotid-femoral and aorto-femoral pulse wave-velocity (PWV) were analyzed by ECG-synchronized ultrasound. Ankle-brachial index (ABI) was determined by Doppler, and forearm skin microcirculation was assessed by Laser Doppler perfusion monitoring.Results
Brachial artery FMD significantly improved upon rosuvastatin therapy (2.2% ± 3.3% before versus 5.7% ± 3.9% after treatment, P = 0.0002). With regard to patient subsets, FMD significantly improved in the 21 lcSSc patients (from 2.1% to 5.6%, P = 0.001). In the seven dcSSc patients, we observed a tendency of improvement in FMD (from 3% to 6%, P = 0.25). Changes in PWV, ccIMT and ABI were not significant. Mean triglyceride (1.7 ± 0.97 versus 1.3 ± 0.46 mmol/l, P = 0.0004), total cholesterol (5.3 ± 1.6 mmol/l versus 4.2 ± 1.3 mmol/l, P = 0.0003), low density lipoprotein cholesterol (3.0 ± 1.3 versus 2.2 ± 1.0 mmol/l, P = 0.005) and C-reactive protein levels (CRP) (5.1 ± 5.2 versus 3.4 ± 2.7, P = 0.01) levels significantly decreased after rosuvastatin treatment. Mean C3, C4 and IC levels also decreased significantly as compared to pretreatment values.Conclusions
Six-month rosuvastatin therapy improves endothelial function and lowers CRP, C3, C4 and IC levels indicating possible favourable effects of this statin on the cardiovascular and immune system in SSc. 相似文献914.
Susanna?Zucca Lorenzo?Pasotti Nicolò?Politi Maria?Gabriella?Cusella De Angelis Paolo?MagniEmail author 《Journal of biological engineering》2013,7(1):12
Background
The chromosomal integration of biological parts in the host genome enables the engineering of plasmid-free stable strains with single-copy insertions of the desired gene networks. Although different integrative vectors were proposed, no standard pre-assembled genetic tool is available to carry out this task. Synthetic biology concepts can contribute to the development of standardized and user friendly solutions to easily produce engineered strains and to rapidly characterize the desired genetic parts in single-copy context.Results
In this work we report the design of a novel integrative vector that allows the genomic integration of biological parts compatible with the RFC10, RFC23 and RFC12 BioBrick? standards in Escherichia coli. It can also be specialized by using BioBrick? parts to target the desired integration site in the host genome. The usefulness of this vector has been demonstrated by integrating a set of BioBrick? devices in two different loci of the E. coli chromosome and by characterizing their activity in single-copy. Construct stability has also been evaluated and compared with plasmid-borne solutions.Conclusions
Physical modularity of biological parts has been successfully applied to construct a ready-to-engineer BioBrick? vector, suitable for a stable chromosomal insertion of standard parts via the desired recombination method, i.e. the bacteriophage integration mechanism or homologous recombination. In contrast with previously proposed solutions, it is a pre-assembled vector containing properly-placed restriction sites for the direct transfer of various formats of BioBrick? parts. This vector can facilitate the characterization of parts avoiding copy number artefacts and the construction of antibiotic resistance-free engineered microbes, suitable for industrial use.915.
916.
Cecilia Cs?lle Mária Baranyi Gabriella Zsilla ágnes Kittel Flóra G?l?ncsér Peter Illes Edit Papp E. Sylvester Vizi Beáta Sperlágh 《PloS one》2013,8(6)
Recent investigations have revealed that the genetic deletion of P2X7 receptors (P2rx7) results in an antidepressant phenotype in mice. However, the link between the deficiency of P2rx7 and changes in behavior has not yet been explored. In the present study, we studied the effect of genetic deletion of P2rx7 on neurochemical changes in the hippocampus that might underlie the antidepressant phenotype. P2X7 receptor deficient mice (P2rx7−/−) displayed decreased immobility in the tail suspension test (TST) and an attenuated anhedonia response in the sucrose preference test (SPT) following bacterial endotoxin (LPS) challenge. The attenuated anhedonia was reproduced through systemic treatments with P2rx7 antagonists. The activation of P2rx7 resulted in the concentration-dependent release of [3H]glutamate in P2rx7+/+ but not P2rx7−/− mice, and the NR2B subunit mRNA and protein was upregulated in the hippocampus of P2rx7−/− mice. The brain-derived neurotrophic factor (BDNF) expression was higher in saline but not LPS-treated P2rx7−/− mice; the P2rx7 antagonist Brilliant blue G elevated and the P2rx7 agonist benzoylbenzoyl ATP (BzATP) reduced BDNF level. This effect was dependent on the activation of NMDA and non-NMDA receptors but not on Group I metabotropic glutamate receptors (mGluR1,5). An increased 5-bromo-2-deoxyuridine (BrdU) incorporation was also observed in the dentate gyrus derived from P2rx7−/− mice. Basal level of 5-HT was increased, whereas the 5HIAA/5-HT ratio was lower in the hippocampus of P2rx7−/− mice, which accompanied the increased uptake of [3H]5-HT and an elevated number of [3H]citalopram binding sites. The LPS-induced elevation of 5-HT level was absent in P2rx7−/− mice. In conclusion there are several potential mechanisms for the antidepressant phenotype of P2rx7−/− mice, such as the absence of P2rx7-mediated glutamate release, elevated basal BDNF production, enhanced neurogenesis and increased 5-HT bioavailability in the hippocampus. 相似文献
917.
918.
919.
920.
Alessio Branchini Matteo Campioni Maria Gabriella Mazzucconi Francesca Biondo Rosella Mari Maria Patrizia Bicocchi Francesco Bernardi Mirko Pinotti 《FEBS letters》2013
The interplay between impaired protein biosynthesis and/or function caused by missense mutations, particularly in relation to specific protein regions, has been poorly investigated. As model we chose the severe p.Y450C mutation in the carboxyl-terminal region of coagulation factor IX (FIX) and, by expression of a panel of recombinant variants, demonstrated the key role of the tyrosine phenyl group for both FIX secretion and coagulant activity. Comparison among highly homologous coagulation serine proteases indicate that additive or compensatory pleiotropic effects on secretion and function by carboxyl-terminal mutations produce life-threatening or mild phenotypes in the presence of similarly reduced protein amounts. 相似文献